Search Results - "Okahata, Sumie"

Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody—insight into the pathogenesis of autoimmune endocrinopathy by Okahata, Sumie, Sakamoto, Kentaro, Mitsumatsu, Takako, Kondo, Yuko, Noso, Shinsuke, Ikegami, Hiroshi, Shiba, Teruo

“…Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer therapy, but…”
Get full text

Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial by Ueki, Kohjiro, Sasako, Takayoshi, Kato, Masayuki, Okazaki, Yukiko, Okahata, Sumie, Katsuyama, Hisayuki, Haraguchi, Mikiko, Morita, Ai, Ohashi, Ken, Hara, Kazuo, Morise, Atsushi, Izumi, Kazuo, Ohashi, Yasuo, Noda, Mitsuhiko, Kadowaki, Takashi

“…ObjectiveMultifactorial intervention including the management of levels of blood glucose (BG), blood pressure (BP), and lipids has been suggested to decrease…”
Get full text

Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody - insight into the pathogenesis of autoimmune endocrinopathy by Sumie Okahata, Kentaro Sakamoto, Takako Mitsumatsu, Yuko Kondo, Shinsuke Noso, Hiroshi Ikegami, Teruo Shiba

“…Abstract. Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer…”
Get full text

Large clinical studies on diabetic retinopathy by Sakamoto, Kentaro, Mitsumatsu, Takako, Okahata, Sumie, Shiba, Teruo

Get more information

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial by Ueki, Kohjiro, Sasako, Takayoshi, Okazaki, Yukiko, Kato, Masayuki, Okahata, Sumie, Katsuyama, Hisayuki, Haraguchi, Mikiko, Morita, Ai, Ohashi, Yasuo, Kadowaki, Takashi, Haneda, Masakazu, Iwashima, Yasunori, Suda, Toshihiro, Satoh, Jo, Takebe, Noriko, Watanabe, Tsuyoshi, Kasai, Kikuo, Ishibashi, Shun, Katayama, Shigehiro, Ishikawa, San-e, Kakei, Masafumi, Namai, Kazuyuki, Suzuki, Yoshifumi, Yokote, Koutaro, Hayashi, Yoichi, Saito, Satoshi, Ogihara, Norikazu, Ishihara, Hisamitsu, Shimada, Akira, Itoh, Hiroshi, Watada, Hirotaka, Mori, Yasumichi, Shiba, Teruo, Isogawa, Akihiro, Hirata, Yukio, Uchimura, Isao, Yoshino, Gen, Hirose, Takahisa, Atsumi, Yoshihito, Oikawa, Yoichi, Ueki, Akio, Ohno, Atsushi, Kitaoka, Masafumi, Fujita, Yoshikuni, Moriya, Tatsumi, Tojo, Taiki, Shichiri, Masayoshi, Suzuki, Daisuke, Hamano, Kumiko, Kuzuya, Nobuaki, Takamura, Toshinari, Tanaka, Hiroshi, Hayashi, Masayuki, Kato, Yasuhisa, Itoh, Mitsuyasu, Nakayama, Mikihiro, Sano, Takahisa, Sumida, Yasuhiro, Tanaka, Tsuyoshi, Kashiwagi, Atsunori, Kono, Shigeo, Yasuda, Tetsuyuki, Yoshimasa, Yasunao, Kishimoto, Ichiro, Sato, Toshihiko, Matsuhisa, Munehide, Shimomura, Iichiro, Kuroe, Akira, Kurose, Takeshi, Ohara, Takeshi, Sakaguchi, Kazuhiko, Namba, Mitsuyoshi, Kaku, Kohei, Fujiwara, Masazumi, Ebisui, Osamu, Tanizawa, Yukio, Kodera, Takehiko, Sato, Naoichi, Ide, Makoto, Yamada, Kentaro, Eto, Tomoaki, Mimura, Kazuo, Hiramatsu, Shinsuke, Inoue, Tomoaki, Takei, Ryoko, Ogo, Atsushi, Kawasaki, Eiji, Araki, Eiichi, Yamamoto, Hiroaki, Hiyoshi, Toru, Sato, Koichiro, Yoneyama, Akihiko, Ito, Kenichi, Sobajima, Hiroshi, Ikeda, Masaki, Ikeda, Hiroki, Takahashi, Kenji, Makino, Hirofumi, Ueda, Yasuo, Nakazato, Masamitsu

“…Limited evidence suggests that multifactorial interventions for control of glucose, blood pressure, and lipids reduce macrovascular complications and mortality…”
Get full text

Effect of GLP-1 receptor agonists on free fatty acids and implication for preventing atherosclerosis by Sakamoto, Kentaro, Okahata, Sumie, Mitsumatsu, Takako, Shiba, Teruo

Get full text

Postprandial hyperglycemia by Okahata, Sumie, Tobe, Kazuyuki, Terauchi, Yasuo

Get more information

Mechanistic insights from sequential combination therapy with a sodium glucose co‐transporter‐2 inhibitor and a dipeptidyl peptidase‐4 inhibitor: Results from the CANARIS Trial using canagliflozin and teneligliptin by Okahata, Sumie, Sakamoto, Kentaro, Mitsumatsu, Takako, Kondo, Yuko, Tanaka, Shoji, Shiba, Teruo

“…Aim To elucidate the mechanisms involved in the sequential use of SGLT2 and DPP4 inhibitors (SGLT2i and DPP‐4i). Methods Twenty‐six type‐2 diabetes mellitus…”
Get full text

d-ROMs and BAP as Potential Predictive Factors for New-Onset Diabetes by OKAHATA, SUMIE, SAKAMOTO, KENTARO, MITSUMATSU, TAKAKO, YANO, MASAO, ISHIZAKA, YUKO, YAMAKADO, MINORU, SHIBA, TERUO

“…Background: Increased oxidative stress plays a role in the progression of atherosclerosis. Yet only few reports in NOD. Method: Derivatives of reactive oxygen…”
Get full text

Extreme Hyperglycemia Causes Vascular Hypoperfusion at Optic Nerve Head in Diabetic Patients (DM) by Mitsumatsu, Takako, Yagi, Fumihiko, Kondo, Yuko, Anraku, Ayako, Okahata, Sumie, Sakamoto, Kentaro, Tomita, Goji, Shiba, Teruo

“…Background: OCT angiography (OCTA) and laser speckle flowgraphy (LSFG) are novel and noninvasive imaging modalities which could evaluate fundus blood flow…”
Get full text

Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody—insight into the pathogenesis of autoimmune endocrinopathy by Okahata, Sumie, Sakamoto, Kentaro, Mitsumatsu, Takako, Kondo, Yuko, Noso, Shinsuke, Ikegami, Hiroshi, Shiba, Teruo

“…Therapeutic blocking antibodies against programmed death 1 (PD1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) are applied for advanced cancer therapy, but…”
Get full text